Nerve agents
- PMID:17215724
- DOI: 10.1097/01.nrl.0000252923.04894.53
Nerve agents
Abstract
Background: Nerve agents, the deadliest of the classic chemical warfare agents, primarily function as acetylcholinesterase inhibitors and cause a rapidly progressive cholinergic crisis. Originally developed for battlefield use, they have been used in terrorist attacks and are considered threats to the civilian population.
Review summary: The pathophysiology and clinical presentation of acute nerve agent poisoning are summarized and acute treatment protocols reviewed. Timely support and antidotal treatment are crucial and may be lifesaving. Pyridostigmine bromide, recently approved by the Food and Drug Administration as a pretreatment for soman poisoning, forms part of battlefield doctrine but is unlikely to be used in the civilian sector. Aside from that, civilian recommendations for acute therapy derive, with only minor modifications, from military doctrine.
Conclusion: Neurologists should familiarize themselves with the pathophysiology and treatment principles for the syndromes caused by nerve agents, not only to assist with the hospital care of these patients but also to serve as resources to their local medical communities in preparation for chemical terrorism. Because nerve agents injure the nervous system, nonneurologists have a right to expect neurologists to have mastered these principles.
Similar articles
- Nerve agents: pathophysiology and treatment of poisoning.Newmark J.Newmark J.Semin Neurol. 2004 Jun;24(2):185-96. doi: 10.1055/s-2004-830906.Semin Neurol. 2004.PMID:15257516Review.
- Therapy for nerve agent poisoning.Newmark J.Newmark J.Arch Neurol. 2004 May;61(5):649-52. doi: 10.1001/archneur.61.5.649.Arch Neurol. 2004.PMID:15148139Review.
- Pharmacologic prophylaxis against nerve agent poisoning.Layish I, Krivoy A, Rotman E, Finkelstein A, Tashma Z, Yehezkelli Y.Layish I, et al.Isr Med Assoc J. 2005 Mar;7(3):182-7.Isr Med Assoc J. 2005.PMID:15792266Review.
- Lessons to be learnt from organophosphorus pesticide poisoning for the treatment of nerve agent poisoning.Thiermann H, Szinicz L, Eyer P, Felgenhauer N, Zilker T, Worek F.Thiermann H, et al.Toxicology. 2007 Apr 20;233(1-3):145-54. doi: 10.1016/j.tox.2006.11.056. Epub 2006 Nov 19.Toxicology. 2007.PMID:17161895
- Bifunctional compounds eliciting anti-inflammatory and anti-cholinesterase activity as potential treatment of nerve and blister chemical agents poisoning.Amitai G, Adani R, Fishbein E, Meshulam H, Laish I, Dachir S.Amitai G, et al.J Appl Toxicol. 2006 Jan-Feb;26(1):81-7. doi: 10.1002/jat.1111.J Appl Toxicol. 2006.PMID:16167317
Cited by
- Neurosteroids as Novel Anticonvulsants for Refractory Status Epilepticus and Medical Countermeasures for Nerve Agents: A 15-Year Journey to Bring Ganaxolone from Bench to Clinic.Reddy DS.Reddy DS.J Pharmacol Exp Ther. 2024 Jan 17;388(2):273-300. doi: 10.1124/jpet.123.001816.J Pharmacol Exp Ther. 2024.PMID:37977814Free PMC article.Review.
- Effectiveness of donepezil, rivastigmine, and (+/-)huperzine A in counteracting the acute toxicity of organophosphorus nerve agents: comparison with galantamine.Aracava Y, Pereira EF, Akkerman M, Adler M, Albuquerque EX.Aracava Y, et al.J Pharmacol Exp Ther. 2009 Dec;331(3):1014-24. doi: 10.1124/jpet.109.160028. Epub 2009 Sep 9.J Pharmacol Exp Ther. 2009.PMID:19741148Free PMC article.
- Effect of acute soman exposure on GABA(A) receptors in rat hippocampal slices and cultured hippocampal neurons.Wang Y, Liu L, Weiss T, Stewart C, Mikler J.Wang Y, et al.Neurotox Res. 2011 Nov;20(4):343-50. doi: 10.1007/s12640-011-9248-9. Epub 2011 Jun 4.Neurotox Res. 2011.PMID:21643853
- Galantamine counteracts development of learning impairment in guinea pigs exposed to the organophosphorus poison soman: clinical significance.Mamczarz J, Kulkarni GS, Pereira EF, Albuquerque EX.Mamczarz J, et al.Neurotoxicology. 2011 Dec;32(6):785-98. doi: 10.1016/j.neuro.2011.07.001. Epub 2011 Jul 19.Neurotoxicology. 2011.PMID:21784098Free PMC article.
- Molecular and cellular actions of galantamine: clinical implications for treatment of organophosphorus poisoning.Pereira EF, Aracava Y, Alkondon M, Akkerman M, Merchenthaler I, Albuquerque EX.Pereira EF, et al.J Mol Neurosci. 2010 Jan;40(1-2):196-203. doi: 10.1007/s12031-009-9234-3. Epub 2009 Aug 19.J Mol Neurosci. 2010.PMID:19690988
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical